Urology
Volume 61, Issue 1 , Pages 15-16 , January 2003

Informed consent for prostate cancer screening—a call for equity in medical interventions

  • Ian M Thompson

      Affiliations

    • Division of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    • Corresponding Author InformationReprint requests: Ian M. Thompson, M.D., Division of Urology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA

Received 6 July 2002 ,Accepted 12 August 2002.

References 

  1. Jagasia DH, Williams B, Ezekowitz MD. Clinical implication of antiembolic trials in atrial fibrillation and role of transesophageal echocardiography in atrial fibrillation. Curr Opin Cardiol. 2000;15:58–63
  2. Oparil S. Long-term morbidity and mortality trials with amlodipine. J Cardiovasc Pharmacol. 1999;33:S1–S6
  3. Little P, Gould C, Moore M, et al.  Predictors of poor outcome and benefits from antibiotics in children with acute otitis media (pragmatic randomized trial). BMJ. 2002;325:22–27
  4. Rajkumar SV, Hartmann LC. Screening mammography in women aged 40–49 years. Medicine. 1999;78:410–416

☆ I. M. Thompson is a member of the speaker’s bureau for AstraZeneca, Inc.

PII: S0090-4295(02)02008-3

Urology
Volume 61, Issue 1 , Pages 15-16 , January 2003

Article Tools